Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience

Published:2018-05 Issue:5 Volume:122 Page:528-532
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Dunlop William C.N.,Staufer Alexandra,Levy Pierre,Edwards Guy J.

Funder

Mundipharma International Ltd

Publisher

Elsevier BV

Subject

Health Policy

Reference19 articles.

1. Global medicines use in 2020: outlook and implications;IMS Health,2015

2. BEACON: a summary framework to overcome potential reimbursement hurdles;Dunlop;PharmacoEconomics,2016

3. Adaptive pathways and patient access: pushing payer boundaries or facilitating new payment models?;Sapede,2016

4. Managing risk and uncertainty in health technology introduction: the role of managed entry agreements;Kavanos;Global Policy,2017

5. Managed entry agreements for pharmaceuticals: the European experience;Ferrario,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®);Value in Health;2024-08

2. Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity;Drug Discovery Today;2024-07

3. The influence of the national drug price negotiation policy reform on the medical expenses of patients in Xuzhou City: an interrupted time series analysis;Frontiers in Public Health;2024-06-05

4. Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries;Frontiers in Pharmacology;2023-11-28

5. A game theory data science-based mechanism for licensed pharmaceutical products concerning their deterioration: a case of a micro, small, and medium enterprise in Iran;Annals of Operations Research;2023-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3